实施心肺复苏并非一定要“口对口”人工呼吸!
(2012-12-25 19:37:32)
标签:
保健心肺复苏口对口呼吸健康 |
分类: 健康要闻 |
路遇心跳骤停的患者,若无专业人员和器械的支持,实施心肺复苏时一定要进行“口对口”人工呼吸吗?最近的研究结果是“不需要”啊!这项源于日本的研究结果提示,路遇心跳骤停的患者,若无专业人员和器械的支持,仅仅实施胸外按压亦可成功地复苏心跳骤停的患者,并且这些被复苏的心跳骤停的患者日后的生存率甚至略高于经实施标准心肺复苏而起死回生的心跳骤停患者。研究同时还指出,这一技术仅仅适用于路遇心跳骤停的成年患者的抢救,即不适合于在医院或社区服务中心由专业人员开展,亦不适合应用于儿童心跳骤停患者的抢救。请大家多注意啊!
Chest compression-only CPR shows
long-term benefit
NEW YORK (Reuters Health) - People who suffer cardiac arrest -
in which the heart stops beating - were less likely to die in
subsequent years when bystanders performed cardiopulmonary
resuscitation using chest compressions only, a new study
found.
That builds on previous research that found no short-term
survival differences in adult victims given compression-only CPR
instead of the standard kind, which includes mouth-to-mouth
resuscitation.
And it supports an American Heart Association recommendation
that the simpler form of CPR is appropriate for bystanders, who may
feel so intimidated by the prospect of combining chest compressions
with rescue breathing that they give no aid at all.
This study shows "we were on the right track in 2008," said
Dr. Roger White of the Mayo Clinic, who was on the advisory group
that wrote the AHA's statement.
The recommendations don't apply to CPR performed in the
hospital, nor in the community by medical personnel or people who
are proficient in rescue breathing. They also apply only to adult,
not pediatric, victims.
Some 383,000 people in the U.S. suffer cardiac arrests every
year, and only about 10 percent survive.
The study looked at data from two randomized trials that were
published in the New England Journal of Medicine in 2010 and
covered more than 3,200 adults whose cardiac arrests were likely
due to heart problems rather than trauma, suffocating or drowning.
Dispatchers instructed bystanders via phone to use either the
standard or compression-only form of CPR.
The new study's authors, who were from Seattle, France and
Sweden, were able to follow up on longer-term outcomes for 78
percent of those participants.
The one-year survival rate was about 12 percent for chest
compression alone and about 10 percent for compression plus
breathing, said Dr. Florence Dumas, an author of the study, in an
email to Reuters Health. After adjusting for different factors,
mortality in the compression-only group was 9 percent lower than in
the standard CPR group. The survival benefit persisted over five
years, according to findings published in the journal
Circulation.
That suggests "that potential short-term outcome differences
do translate to meaningful long-term public health benefits," said
Dumas.
ALLAYING CONCERNS
In 2008 the AHA said compression-only CPR was an option for
bystanders who aren't trained or who aren't confident in their
ability to perform the compressions combined with rescue
breathing.
Some people have worried that collapsed victims of non-cardiac
events such as drug overdoses or a blood clot in the lungs might
not get the oxygen they need with the compression-only approach, he
said.
But the study authors wrote that, "importantly, we did not
observe evidence of harm among those for whom oxygenation and
ventilation might in theory be more important" such as non-cardiac
causes or an unwitnessed cardiac arrest.
There is likely some oxygen remaining in the blood when a
victim's heart has stopped for a short period of time, and the
compression-only technique can distribute it to vital organs. If a
person has been down for a longer or unknown period of time, it's
more likely that they'll need fresh oxygen through rescue
breathing, said White, an anesthesiologist and cardiac care
specialist who was not involved in the new study.
That's why the AHA's recommendations apply when bystanders
actually witness an adult suffering cardiac arrest with no obvious
non-cardiac cause such as drowning. (Kids suffering cardiac arrest
need rescue breathing.)
"The vast majority (of events) are likely to be cardiac in
origin," said White. "So proceeding with chest compression is
likely to be beneficial in the vast majority of cases," he
said.
One limitation of the study was that it tracked survival only;
it couldn't assess patients' level of function or quality of life.
In addition, the original trials the study drew from weren't
designed to track long-term outcomes.
SOURCE: Circulation,
online December 10, 2012.